Transscleral passive and iontophoretic transport: theory and analysis
- PMID: 29149574
- DOI: 10.1080/17425247.2018.1406918
Transscleral passive and iontophoretic transport: theory and analysis
Abstract
Introduction: The sclera is considered the 'static barrier,' a main barrier for transscleral drug delivery. The characterization of passive and iontophoretic transport across the sclera in vitro is the first step toward our ability to predict transscleral drug delivery. Although previous studies have investigated this topic, the quantitative structure permeation relationships (QSPR) for passive and iontophoretic transscleral transport are not available.
Areas covered: This review evaluated previous results of transscleral passive and iontophoretic transport in vitro and examined QSPR for transscleral permeation of small permeants and macromolecules. Passive permeation data in the literature were compared with respective to the animal species employed in the studies. Data variability was investigated. Electrotransport theory and the mechanisms of iontophoresis were reviewed and used to analyze the iontophoresis data.
Expert opinion: QSPR was examined for passive transscleral permeation, showing correlations between logarithm of permeability coefficient and logarithm of molecular weight. Potential causes of data variability were proposed. QSPR were established for electroosmosis using the molecular weight of neutral permeants and for iontophoresis enhancement using the molecular weight and charge of ionic permeants. However, QSPR for charged macromolecules were empirical; iontophoretic flux enhancement was significantly smaller than Nernst-Planck model prediction due to complicating factors.
Keywords: Ocular delivery; diffusion; iontophoresis; quantitative structure permeation relationships (QSPR); sclera; transscleral.
Similar articles
-
In vitro permeability of a model protein across ocular tissues and effect of iontophoresis on the transscleral delivery.Eur J Pharm Biopharm. 2014 Sep;88(1):116-22. doi: 10.1016/j.ejpb.2014.04.018. Epub 2014 May 9. Eur J Pharm Biopharm. 2014. PMID: 24816128
-
Iontophoretic transport of charged macromolecules across human sclera.Int J Pharm. 2010 Mar 30;388(1-2):107-13. doi: 10.1016/j.ijpharm.2009.12.046. Epub 2010 Jan 5. Int J Pharm. 2010. PMID: 20045044 Free PMC article.
-
Examination of penetration routes and distribution of ionic permeants during and after transscleral iontophoresis with magnetic resonance imaging.Int J Pharm. 2007 Apr 20;335(1-2):46-53. doi: 10.1016/j.ijpharm.2006.11.001. Epub 2006 Nov 3. Int J Pharm. 2007. PMID: 17236728 Free PMC article.
-
Basic principles and current status of transcorneal and transscleral iontophoresis.Expert Opin Drug Deliv. 2017 Sep;14(9):1091-1102. doi: 10.1080/17425247.2017.1266334. Epub 2016 Dec 11. Expert Opin Drug Deliv. 2017. PMID: 27892757 Review.
-
Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier.Adv Drug Deliv Rev. 2013 Feb;65(2):315-29. doi: 10.1016/j.addr.2012.04.012. Epub 2012 May 22. Adv Drug Deliv Rev. 2013. PMID: 22626977 Review.
Cited by
-
Management of retinitis pigmentosa by Wharton's jelly-derived mesenchymal stem cells: prospective analysis of 1-year results.Stem Cell Res Ther. 2020 Aug 12;11(1):353. doi: 10.1186/s13287-020-01870-w. Stem Cell Res Ther. 2020. PMID: 32787913 Free PMC article. Clinical Trial.
-
Multi-physics simulations for investigating the effect of electrode conditions on transscleral ocular iontophoresis for particulate drug delivery into ocular tissues.Biomed Eng Lett. 2024 Feb 12;14(3):439-450. doi: 10.1007/s13534-024-00359-2. eCollection 2024 May. Biomed Eng Lett. 2024. PMID: 38645594 Free PMC article.
-
Management of retinitis pigmentosa by Wharton's jelly derived mesenchymal stem cells: preliminary clinical results.Stem Cell Res Ther. 2020 Jan 13;11(1):25. doi: 10.1186/s13287-020-1549-6. Stem Cell Res Ther. 2020. PMID: 31931872 Free PMC article.
-
Management of toxic optic neuropathy via a combination of Wharton's jelly-derived mesenchymal stem cells with electromagnetic stimulation.Stem Cell Res Ther. 2021 Sep 27;12(1):518. doi: 10.1186/s13287-021-02577-2. Stem Cell Res Ther. 2021. PMID: 34579767 Free PMC article. Clinical Trial.
-
Photokinetic Drug Delivery: Near infrared (NIR) Induced Permeation Enhancement of Bevacizumab, Ranibizumab and Aflibercept through Human Sclera.Pharm Res. 2018 Mar 29;35(6):110. doi: 10.1007/s11095-018-2392-7. Pharm Res. 2018. PMID: 29600470 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources